CLINICAL_TRIALS
trial_result
· 2019-01-18
Clinical Trial Update: A Study of LY2584702 in Participants With Advanced Cancer [Phase 1]
Summary
Phase 1 study of LY2584702 in participants with advanced cancer was terminated; results were posted on 2019-01-18.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-01-18